A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review

Laryngoscope

Volumn 124, Issue 9, 2014, Pages 2096-2102

  De Almeida, John R ^a   Byrd, James K ^b   Wu, Rebecca ^c   Stucken, Chaz L ^c   Duvvuri, Uma ^b   Goldstein, David P ^a   Miles, Brett A ^c   Teng, Marita S ^c   Gupta, Vishal ^c   Genden, Eric M ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

adverse events; IMRT; oropharynx cancer; outcomes; survival; TORS

Indexed keywords

ANTINEOPLASTIC AGENT;

BIBLIOGRAPHIC DATABASE; BONE NECROSIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CINAHL; COMPARATIVE EFFECTIVENESS; CONSENSUS; DATA EXTRACTION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EMBASE; ESOPHAGUS STENOSIS; FISTULA; HOSPITAL DISCHARGE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MEDLINE; META ANALYSIS; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; ORAL SURGERY; OROPHARYNX CANCER; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PSYCINFO; REVIEW; ROBOTICS; STOMACH TUBE; SYSTEMATIC REVIEW; TRACHEOSTOMY; TRACHEOSTOMY TUBE; TRANSORAL ROBOTIC SURGERY;

ADVERSE EVENTS; IMRT; OROPHARYNX CANCER; OUTCOMES; SURVIVAL; TORS;

COMBINED MODALITY THERAPY; HUMANS; MOUTH; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED; ROBOTICS;

EID: 84906656639     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24712     Document Type: Review

References (36)

1. Weinstein GS, O'Malley BW Jr, Hockstein NG,. Transoral robotic surgery: supraglottic laryngectomy in a canine model. Laryngoscope 2005; 115: 1315-1319.
2. Hockstein NG, Weinstein GS, O'Malley BW Jr,. Maintenance of hemostasis in transoral robotic surgery. ORL J Otorhinolaryngol Relat Spec 2005; 67: 220-224.
3. Hockstein NG, O'Malley BW Jr, Weinstein GS,. Assessment of intraoperative safety in transoral robotic surgery. Laryngoscope 2006; 116: 165-168.
4. Iseli TA, Kulbersh BD, Iseli CE, et al. Functional outcomes after transoral robotic surgery for head and neck cancer. Otolaryngol Head Neck Surg 2009; 141: 166-171.
5. White HN, Moore EJ, Rosenthal EL, et al. Transoral robotic-assisted surgery for head and neck squamous cell carcinoma: one and 2 year survival analysis. Arch Otolaryngol Head Neck Surg 2010; 136: 1248-1252.
6. Al-Mamgani A, van Rooij P, Verduijn GM, Mehilal R, Kerrebijn JN, Levendag PC,. The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer. Laryngoscope 2013; 123: 386-393.
7. Hunter KU, Schipper M, Feng FY, et al. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes. Int J Radiat Oncol Biol Phys 2013; 85: 935-940.
8. Pignon JP, le Maitre A, Maillard E, Bourhis J, MACH-NC Collaborative Group,. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14.
9. Nichols AC, Yoo J, Hammond JA, et al. Early stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)-study protocol for a randomized phase II trial. BMC Cancer 2013;2013: 133.
10. Adelstein DJ, Ridge JA, Brizel DM, et al. Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head Neck 2012; 34: 1681-1703.
11. Genden EM, Kotz T, Tong CC, et al. Transoral robotic resection and reconstruction for head and neck cancer. Laryngoscope 2011; 121: 1668-1674.
12. Moga C, Guo B, Schopflocher D, Harstall C,. Development of a quality appraisal tool for case series studies using a modified Delphi technique. http://www.ihe.ca/documents/Case%20series%20studies%20using%20a%2 0modified%20Delphi%20technique.pdf. Downloaded May 1, 2013.
13. De Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2006; 64: 363-373.
14. Eisbruch A, Harris J, Garen AS, et al. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys 2010; 76: 1333-1338.
15. Galloway TJ, Turaka A, Ruth K, et al. Low rates of gastrostomy tube dependence in patients with T1-T2 Oropharynx Cancer treated without pharyngeal constrictor sparing. Int J Radiat Oncol Biol Physics 2011; 81: (suppl): 2614.
16. Garden AS, Morrison WH, Wong PF, et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007; 67: 438-444.
17. Garden AS, Dong L, Morrison WH, et al. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 2013; 85: 941-947.
18. Hodge CW, Bentzen SM, Wong G, et al. Are we influencing outcome in oropharynx cancer with intensity modulated radiotherapy? An inter-era comparison. Int J Radiation Oncol Biol Physc 2007; 69: 1032-1041.
19. Mendenhall WM, Amdur RJ, Morris CG, Kirwan JM, Li JG,. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma. Laryngoscope 2010; 120: 2218-2222.
20. Sher DJ, Thotakura V, Balboni TA, et al. Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy. Ann Oncol 2012; 23: 2391-2398. doi: 10.1093/annonc/mdr609. Epub 2012.
21. Cohen MA, Weinstein GS, O'Malley BW, et al. Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck 2011; 33: 573-580.
22. de Almeida JR, Holsinger FC, Duvvuri U, et al. Oncologic outcomes following transoral robotic surgery (TORS) for Oropharyngeal cancer: a multi-institutional study. Presented at 8th International Conference for Head and Neck Cancer Meeting; Toronto, Canada, July 22, 2012.
23. Dean NR, Rosenthal EL, Carroll WR, et al. Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2010; 136: 380-384.
24. Genden EM, Park R, Smith C, Kotz T,. The role of reconstruction for transoral robotic pharyngectomy and concomitant neck dissection. Arch Otolaryngol Head Neck Surg 2011; 137: 151-156.
25. Moore EJ, Olsen SM, Laborde RR, et al. Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clinic Proc 2012; 87: 219-225.
26. Moore EJ, Olsen KD, Martin EJ,. Concurrent neck dissection and transoral robotic surgery. Laryngoscope 2011; 121: 541-544.
27. Quon H, Cohen MA, Montone KT, et al. Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes. Laryngoscope 2013; 123: 635-640.
28. Sinclair CF, McColloch NL, Carroll WR, Rosenthal EL, Desmond RA, Magnuson JS,. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2011; 137: 1112-1116.
29. Weinstein GS, O'Malley BW Jr, Snyder W, Sherman E, Quon H,. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 2007; 133: 1220-1226.
30. Weinstein GS, Quon H, O'Malley BW Jr, Kim GG, Cohen MA,. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial. Laryngoscope 2010; 120: 1749-1755.
31. Weinstein GS, O'Malley BW Jr, Cohen MA, Quon H,. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2010; 136: 1079-1085.
32. Weinstein GS, Quon H, Newman HJ, et al. Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. Arch Otolaryngol Head Neck Surg 2012; 138: 628-634.
33. O'Sullivan B, Warde P, Grice B, et al. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 2001; 51: 332-343.
34. de Almeida JR, Villanueva NL, Moskowitz AJ, et al. Preferences and utilities for health states following treatment for oropharyngeal cancer: transoral robotic surgery versus definitive (chemo)radiotherapy. Head Neck 2013. doi: 10.1002/hed.23340. Epub ahead of print.
35. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-4301.
36. Haughey BH, Sinha P,. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope 2012; 122 (suppl 2): S13-33.